Pharmacokinetics of Telbivudine in Subjects with Various Degrees of Hepatic Impairment

This study evaluated the effect of hepatic impairment on the pharmacokinetics of telbivudine, an investigational nucleoside antiviral for the treatment of chronic hepatitis B virus infection. Twenty-four subjects were assigned to four hepatic function groups (normal function and mild, moderate, and...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Zhou, Xiao-Jian, Marbury, Thomas C., Alcorn, Harry W., Smith, William B., Dubuc Patrick, Gloria, Chao, George C., Brown, Nathaniel A.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology 2006
Pynciau:
Antiviral Agents
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1472205/
https://ncbi.nlm.nih.gov/pubmed/16641441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.5.1721-1726.2006
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg